Ms. Reid et al., PARTIAL REVERSAL OF STRESS-INDUCED BEHAVIORAL SENSITIZATION TO AMPHETAMINE FOLLOWING METYRAPONE TREATMENT, Brain research, 783(1), 1998, pp. 133-142
Several studies indicate that blockade of stress-induced corticosteron
e secretion prevents the development of stress-induced sensitization t
o the behavioral effects of stimulants. The present study examined whe
ther chronic blockade of corticosterone synthesis with metyrapone coul
d reverse stress-induced amphetamine sensitization in rats. Restraint
stress in cylindrical chambers, 2 times 30 min/day for 5 days over an
8-day schedule, was used as the stressor. Following completion of the
stress protocol, animals were cannulated with microdialysis guide cann
ulae over the nucleus accumbens, and then treated with either metyrapo
ne (50 mg/kg, i.p.) or vehicle (1 ml/kg) for 7 days. On the seventh da
y, animals were implanted with microdialysis probes in the nucleus acc
umbens, and on the following day, all animals were tested for their lo
comotor, stereotypy, and nucleus accumbens dopamine and DOPAC release
responses to an injection of saline followed 60 min later by D-ampheta
mine (1.5 mg/kg, i.p.). Neither stress or metyrapone treatment had an
effect on the behavioral or dopamine release response to saline. Howev
er, amphetamine-stimulated locomotion and stereotypy were strongly enh
anced, while amphetamine-stimulated dopamine release response was slig
htly enhanced (significant only by drug X time interaction), in stress
ed animals. Metyrapone treatment reduced the stress-induced increase i
n the locomotor, but not stereotypy, response to amphetamine. In contr
ast, the dopamine release response to amphetamine was enhanced in mety
rapone-treated animals, in both stressed and non-stressed groups, whil
e DOPAC levels were unaffected by treatment group. This augmentation w
as particularly evident in the stressed-metyrapone-treated animals. Fu
rthermore, non-stressed animals showed an increased locomotor and ster
eotypy response to amphetamine after treatment with metyrapone. These
findings indicate that metyrapone treatment can reverse, or inhibit th
e expression of, stress-induced sensitization to the behavioral effect
s of amphetamine. However, the ability of metyrapone treatment to enha
nce the behavioral (in non-stressed animals) and dopamine release (in
non-stressed and stressed animals) responses to amphetamine indicate t
hat chronic metyrapone treatment will produce stimulant sensitization
when given alone. (C) 1998 Elsevier Science B.V.